Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Prostatic Neoplasms 5Lung Neoplasms 4Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Recurrence 2Neoplasm Metastasis 2Malignant Neoplasms of Independent (Primary) Multiple Sites 2Lung Diseases 2Head and Neck Neoplasms 2cyclopia sequence 1Tobacco Use Cessation 1Smoke Inhalation Injury 1Sezary Syndrome 1Seroma 1Sarcoma 1Respiratory Aspiration 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polyneuropathies 1Peripheral Nervous System Diseases 1Patient Education 1Pain 1Ovarian Neoplasms 1Occupational Stress 1Neoplasms, Plasma Cell 1Mycosis Fungoides 1Mouth Neoplasms 1Mesothelioma 1Malignant Neoplasms of Female Genital Organs 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Pemetrexed 2Cisplatin 2talazoparib 1poly ICLC 1pembrolizumab 1milademetan 1atezolizumab 1Vorinostat 1Talc 1Surveys and Questionnaires 1Cryosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Mesothelioma × Surveys and Questionnaires × Clear all
NCT02511600 2015-12-15

Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication

M.D. Anderson Cancer Center

Phase 3 Withdrawn
Other solid neoplasmThoracic

Lung Diseases, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡